UniProt ID | CDK14_HUMAN | |
---|---|---|
UniProt AC | O94921 | |
Protein Name | Cyclin-dependent kinase 14 | |
Gene Name | CDK14 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 469 | |
Subcellular Localization |
Cell membrane Peripheral membrane protein. Cytoplasm. Nucleus. Recruited to the cell membrane by CCNY. |
|
Protein Description | Serine/threonine-protein kinase involved in the control of the eukaryotic cell cycle, whose activity is controlled by an associated cyclin. Acts as a cell-cycle regulator of Wnt signaling pathway during G2/M phase by mediating the phosphorylation of LRP6 at 'Ser-1490', leading to the activation of the Wnt signaling pathway. Acts as a regulator of cell cycle progression and cell proliferation via its interaction with CCDN3. Phosphorylates RB1 in vitro, however the relevance of such result remains to be confirmed in vivo. May also play a role in meiosis, neuron differentiation and may indirectly act as a negative regulator of insulin-responsive glucose transport.. | |
Protein Sequence | MCDLIEPQPAEKIGKMKKLRRTLSESFSRIALKKDDTTFDEICVTKMSTRNCQGMDSVIKPLDTIPEDKKVRVQRTQSTFDPFEKPANQVKRVHSENNACINFKTSSTGKESPKVRRHSSPSSPTSPKFGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPDNVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSSKNLRQAWNKLSYVNHAEDLASKLLQCSPKNRLSAQAALSHEYFSDLPPRLWELTDMSSIFTVPNVRLQPEAGESMRAFGKNNSYGKSLSNSKH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
22 | Phosphorylation | KMKKLRRTLSESFSR HHHHHHHHHHHHHHH | 28.36 | 29255136 | |
24 | Phosphorylation | KKLRRTLSESFSRIA HHHHHHHHHHHHHHH | 30.49 | 23401153 | |
26 | Phosphorylation | LRRTLSESFSRIALK HHHHHHHHHHHHHCC | 25.75 | 29255136 | |
28 | Phosphorylation | RTLSESFSRIALKKD HHHHHHHHHHHCCCC | 31.86 | 23403867 | |
45 | Phosphorylation | TFDEICVTKMSTRNC CHHHHHEEECCCCCC | 19.33 | 29083192 | |
48 | Phosphorylation | EICVTKMSTRNCQGM HHHEEECCCCCCCCC | 26.27 | 29083192 | |
49 | Phosphorylation | ICVTKMSTRNCQGMD HHEEECCCCCCCCCC | 23.54 | 29083192 | |
60 | Phosphorylation | QGMDSVIKPLDTIPE CCCCCCCCCCCCCCC | 37.05 | 24719451 | |
76 | Phosphorylation | KKVRVQRTQSTFDPF CCEEEEEECCCCCCC | 15.13 | 30266825 | |
77 | Phosphorylation | KVRVQRTQSTFDPFE CEEEEEECCCCCCCC | 42.54 | 24719451 | |
78 | Phosphorylation | VRVQRTQSTFDPFEK EEEEEECCCCCCCCC | 30.35 | 23401153 | |
79 | Phosphorylation | RVQRTQSTFDPFEKP EEEEECCCCCCCCCC | 23.41 | 30266825 | |
85 | Ubiquitination | STFDPFEKPANQVKR CCCCCCCCCHHHCEE | 50.22 | - | |
94 | Phosphorylation | ANQVKRVHSENNACI HHHCEEECCCCCEEE | 33.17 | 24719451 | |
95 | Phosphorylation | NQVKRVHSENNACIN HHCEEECCCCCEEEE | 38.88 | 23401153 | |
101 | Phosphorylation | HSENNACINFKTSST CCCCCEEEEEECCCC | 6.71 | 24719451 | |
104 | Phosphorylation | NNACINFKTSSTGKE CCEEEEEECCCCCCC | 42.90 | 27251275 | |
105 | Phosphorylation | NACINFKTSSTGKES CEEEEEECCCCCCCC | 24.63 | 27251275 | |
106 | Phosphorylation | ACINFKTSSTGKESP EEEEEECCCCCCCCC | 26.88 | 26699800 | |
107 | Phosphorylation | CINFKTSSTGKESPK EEEEECCCCCCCCCC | 46.54 | 26699800 | |
108 | Phosphorylation | INFKTSSTGKESPKV EEEECCCCCCCCCCC | 52.63 | 26699800 | |
112 | Phosphorylation | TSSTGKESPKVRRHS CCCCCCCCCCCCCCC | 33.24 | 28985074 | |
116 | Phosphorylation | GKESPKVRRHSSPSS CCCCCCCCCCCCCCC | 36.40 | 24719451 | |
119 | Phosphorylation | SPKVRRHSSPSSPTS CCCCCCCCCCCCCCC | 41.98 | 23927012 | |
120 | Phosphorylation | PKVRRHSSPSSPTSP CCCCCCCCCCCCCCC | 23.75 | 23927012 | |
122 | Phosphorylation | VRRHSSPSSPTSPKF CCCCCCCCCCCCCCC | 51.39 | 23927012 | |
123 | Phosphorylation | RRHSSPSSPTSPKFG CCCCCCCCCCCCCCC | 35.26 | 23927012 | |
125 | Phosphorylation | HSSPSSPTSPKFGKA CCCCCCCCCCCCCCC | 60.66 | 23927012 | |
126 | Phosphorylation | SSPSSPTSPKFGKAD CCCCCCCCCCCCCCC | 29.49 | 23927012 | |
134 | Phosphorylation | PKFGKADSYEKLEKL CCCCCCCCHHHHHHH | 39.80 | 23401153 | |
135 | Phosphorylation | KFGKADSYEKLEKLG CCCCCCCHHHHHHHC | 20.03 | 23403867 | |
140 | Ubiquitination | DSYEKLEKLGEGSYA CCHHHHHHHCCCCCE | 72.70 | - | |
145 | Phosphorylation | LEKLGEGSYATVYKG HHHHCCCCCEEEEEC | 13.80 | 27155012 | |
146 | Phosphorylation | EKLGEGSYATVYKGK HHHCCCCCEEEEECC | 19.69 | 25884760 | |
148 | Phosphorylation | LGEGSYATVYKGKSK HCCCCCEEEEECCCC | 19.01 | 27155012 | |
154 | Phosphorylation | ATVYKGKSKVNGKLV EEEEECCCCCCCEEE | 50.97 | 23909892 | |
183 | Phosphorylation | FTAIREASLLKGLKH CHHHHHHHHHHCCHH | 29.49 | 24719451 | |
202 | Phosphorylation | LLHDIIHTKETLTLV EEEEHHCCHHHHHHH | 21.84 | - | |
271 | Ubiquitination | ISDTGELKLADFGLA ECCCCCEEEHHHCCC | 37.01 | - | |
297 | Phosphorylation | NEVVTLWYRPPDVLL CCEEEEEECCCCEEC | 19.16 | 22817900 | |
387 | Phosphorylation | RQAWNKLSYVNHAED HHHHHHHHCCCHHHH | 28.75 | 29083192 | |
388 | Phosphorylation | QAWNKLSYVNHAEDL HHHHHHHCCCHHHHH | 18.73 | 29083192 | |
397 | Phosphorylation | NHAEDLASKLLQCSP CHHHHHHHHHHCCCC | 31.00 | 29083192 | |
403 | Phosphorylation | ASKLLQCSPKNRLSA HHHHHCCCCCCCHHH | 26.42 | 29083192 | |
450 | Phosphorylation | LQPEAGESMRAFGKN ECCCCHHHHHHHCCC | 16.79 | 23403867 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CDK14_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CDK14_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CDK14_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SEPT8_HUMAN | SEPT8 | physical | 12098780 | |
CCND3_HUMAN | CCND3 | physical | 17517622 | |
CDN1A_HUMAN | CDKN1A | physical | 17517622 | |
CCNY_HUMAN | CCNY | physical | 19524571 | |
CDK14_HUMAN | CDK14 | physical | 19524571 | |
RB_HUMAN | RB1 | physical | 19524571 | |
RB_HUMAN | RB1 | physical | 17517622 | |
CDK14_HUMAN | CDK14 | physical | 23602568 | |
CDN1A_HUMAN | CDKN1A | physical | 23602568 | |
RBM14_HUMAN | RBM14 | physical | 23602568 | |
KCC1A_HUMAN | CAMK1 | physical | 23602568 | |
TOP1_HUMAN | TOP1 | physical | 23602568 | |
CCNY_HUMAN | CCNY | physical | 24794231 | |
CDK17_HUMAN | CDK17 | physical | 26186194 | |
ICK_HUMAN | ICK | physical | 26186194 | |
CDN1A_HUMAN | CDKN1A | physical | 26186194 | |
ICK_HUMAN | ICK | physical | 28514442 | |
FGR_HUMAN | FGR | physical | 28514442 | |
CDN1A_HUMAN | CDKN1A | physical | 28514442 | |
CDK17_HUMAN | CDK17 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-22; SER-24; THR-76;SER-95; SER-119; SER-120; SER-122; SER-123 AND SER-134, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24; SER-95 AND SER-134,AND MASS SPECTROMETRY. |